{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:14:10Z","timestamp":1787616850403,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangsu Training Program of Innovation and Entrepreneurship for Undergraduates","award":["202310313020Z"],"award-info":[{"award-number":["202310313020Z"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Malignant hyperthermia is a rare and highly lethal anesthesia emergency. We summarized the published articles on malignant hyperthermia to understand its development trends and provided meaningful recommendations for reducing the mortality rate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The Web of Science core, PubMed Central and Scopus databases were searched from 1975 to 2024 to identify articles related to malignant hyperthermia. The retrieved documents were exported as full-text records via CiteSpace 6.4. R1 and R (BiblioShiny packages) were used to measure and visually analyze the number of articles, journals, keywords, and references.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>According to the bibliometric analysis, 1473 publications were published by research teams across 60 countries and regions. In 1473 publications, advanced economies accounted for 87.78% (<jats:italic>n<\/jats:italic>\u2009=\u20091303), while emerging and developing economies accounted for 12.22% (<jats:italic>n<\/jats:italic>\u2009=\u2009170). In the past 40 years, advanced economies have dominated the field of MH research. The research on MH in emerging and developing economies have been rapidly increasing since 2010. Emerging and developing economies were paying more attention to MH diagnosis and the specific drug dantrolene. The most prolific country was the United States (<jats:italic>n<\/jats:italic>\u2009=\u2009439, centrality\u2009=\u20090.55). The University of California System (<jats:italic>n<\/jats:italic>\u2009=\u200944, centrality\u2009=\u20090.04) had the highest number of articles. The journal ANESTHESIOLOGY was cocited 731 times and had the highest number of cocitations. From the timeline of keyword appearance, attention was devoted to dantrolene and succinylcholine in the 1980s. Since the 1990s, more research has focused on MH susceptibility and ryanodine receptors. Recently, amide anesthetics and spinal anesthesia-induced MH have received more attention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We revealed the evolutionary path of MH research through bibliometric analysis. Owing to the lack of dantrolene and cooperation mechanisms in developing countries, the mortality rate caused by MH is still high. The government and pharmaceutical companies should collaborate to assist the availability and accessibility of dantrolene in developing countries.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03766-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:05:02Z","timestamp":1751367902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Research hotspots and trends in malignant hyperthermia due to anesthesia from a global perspective: a bibliometric analysis from 1975 to 2024"],"prefix":"10.1186","volume":"20","author":[{"given":"Hou-Ming","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Zhao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Liu","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"12","key":"3766_CR1","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1097\/CCM.0000000000006401","volume":"52","author":"T Pinyavat","year":"2024","unstructured":"Pinyavat T, Riazi S, Deng J, Slessarev M, Cuthbertson BH, Ibarra MC, et al. Malignant hyperthermia. Crit Care Med. 2024;52(12):1934\u201340. https:\/\/doi.org\/10.1097\/CCM.0000000000006401.","journal-title":"Crit Care Med"},{"key":"3766_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cge.14475","volume":"105","author":"Z Cong","year":"2024","unstructured":"Cong Z, Wan T, Wang J, Feng L, Cao C, Li Z, et al. Epidemiological and clinical features of malignant hyperthermia: A scoping review. Clin Genet. 2024;105:233\u201342. https:\/\/doi.org\/10.1111\/cge.14475.","journal-title":"Clin Genet"},{"key":"3766_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.bja.2024.05.046","volume":"133","author":"MC Ibarra","year":"2024","unstructured":"Ibarra MC, Silva H, Voermans NC, Jungbluth H, van den Bersselaar LR, Rendu J, et al. Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review. Br J Anaesth. 2024;133:759\u201367. https:\/\/doi.org\/10.1016\/j.bja.2024.05.046.","journal-title":"Br J Anaesth"},{"key":"3766_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5847\/wjem.j.1920-8642.2024.006","volume":"15","author":"J Su","year":"2024","unstructured":"Su J, Huang M. Recurrent malignant hyperthermia after scoliosis correction surgery. World J Emerg Med. 2024;15:70\u20132. https:\/\/doi.org\/10.5847\/wjem.j.1920-8642.2024.006.","journal-title":"World J Emerg Med"},{"key":"3766_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s12630-013-0005-9","volume":"60","author":"D Orlov","year":"2013","unstructured":"Orlov D, Keith J, Rosen D, Croul S, Kraeva N, Riazi S. Analysis of histomorphology in malignant hyperthermia-susceptible patients. Can J Anaesth. 2013;60:982\u20139. https:\/\/doi.org\/10.1007\/s12630-013-0005-9.","journal-title":"Can J Anaesth"},{"key":"3766_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","volume":"118","author":"S Riazi","year":"2014","unstructured":"Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg. 2014;118:381\u20137. https:\/\/doi.org\/10.1213\/ANE.0b013e3182937d8b.","journal-title":"Anesth Analg"},{"key":"3766_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bja\/aev225","volume":"115","author":"PM Hopkins","year":"2015","unstructured":"Hopkins PM, Ruffert H, Snoeck MM, Girard T, Glahn KP, Ellis FR, et al. European malignant hyperthermia group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth. 2015;115:531\u20139. https:\/\/doi.org\/10.1093\/bja\/aev225.","journal-title":"Br J Anaesth"},{"key":"3766_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bja.2020.04.089","volume":"125","author":"K Glahn","year":"2020","unstructured":"Glahn K, Bendixen D, Girard T, Hopkins PM, Johannsen S, Ruffert H, et al. Availability of Dantrolene for the management of malignant hyperthermia crises: European malignant hyperthermia group guidelines. Br J Anaesth. 2020;125:133\u201340. https:\/\/doi.org\/10.1016\/j.bja.2020.04.089.","journal-title":"Br J Anaesth"},{"key":"3766_CR9","doi-asserted-by":"publisher","first-page":"e223994","DOI":"10.1371\/journal.pone.0223994","volume":"14","author":"C Chen","year":"2019","unstructured":"Chen C, Song M. Visualizing a field of research: A methodology of systematic scientometric reviews. PLoS ONE. 2019;14:e223994. https:\/\/doi.org\/10.1371\/journal.pone.0223994.","journal-title":"PLoS ONE"},{"key":"3766_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s44254-023-00030-6","volume":"1","author":"Y Han","year":"2023","unstructured":"Han Y, Qu Y, Wang X, Zhou Y, Yang L, Du H, et al. The 100 most cited articles in malignant hyperthermia. Anaesth Perioper Sci. 2023;1:32. https:\/\/doi.org\/10.1007\/s44254-023-00030-6.","journal-title":"Anaesth Perioper Sci"},{"key":"3766_CR11","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.2147\/JPR.S365524","volume":"15","author":"H Kan","year":"2022","unstructured":"Kan H, Fan L, Gui X, Li X, Yang S, Huang Y, et al. Stem cell therapy for neuropathic pain: A bibliometric and visual analysis. J Pain Res. 2022;15:1797\u2013811. https:\/\/doi.org\/10.2147\/JPR.S365524.","journal-title":"J Pain Res"},{"key":"3766_CR12","doi-asserted-by":"publisher","first-page":"105300","DOI":"10.1016\/j.neubiorev.2023.105300","volume":"152","author":"M Sabe","year":"2023","unstructured":"Sabe M, Sulstarova A, Chen C, Hyde J, Poulet E, Aleman A, et al. A century of research on neuromodulation interventions: A scientometric analysis of trends and knowledge maps. Neurosci Biobehav Rev. 2023;152:105300. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105300.","journal-title":"Neurosci Biobehav Rev"},{"issue":"6258","key":"3766_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/343559a0","volume":"343","author":"DH MacLennan","year":"1990","unstructured":"MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, et al. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature. 1990;343(6258):559\u201361. https:\/\/doi.org\/10.1038\/343559a0.","journal-title":"Nature"},{"issue":"5018","key":"3766_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.1862346","volume":"253","author":"J Fujii","year":"1991","unstructured":"Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, et al. Identification of a mutation in Porcine Ryanodine receptor associated with malignant hyperthermia. Science. 1991;253(5018):448\u201351. https:\/\/doi.org\/10.1126\/science.1862346.","journal-title":"Science"},{"issue":"4","key":"3766_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/00000542-199404000-00009","volume":"80","author":"M Lopez","year":"1994","unstructured":"Lopez M, Sessler DI, Walter K, Emerick T, Ozaki M. Rate and gender dependence of the sweating, vasoconstriction, and shivering thresholds in humans. Anesthesiology. 1994;80(4):780\u20138. https:\/\/doi.org\/10.1097\/00000542-199404000-00009.","journal-title":"Anesthesiology"},{"key":"3766_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis. 2007;2:21. https:\/\/doi.org\/10.1186\/1750-1172-2-21.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"3766_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","volume":"110","author":"MG Larach","year":"2010","unstructured":"Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010;110(2):498\u2013507. https:\/\/doi.org\/10.1213\/ANE.0b013e3181c6b9b2.","journal-title":"Anesth Analg"},{"key":"3766_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","volume":"10","author":"H Rosenberg","year":"2015","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015;10:93. https:\/\/doi.org\/10.1186\/s13023-015-0310-1.","journal-title":"Orphanet J Rare Dis"},{"key":"3766_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","volume":"128","author":"S Riazi","year":"2018","unstructured":"Riazi S, Kraeva N, Hopkins PM. Malignant hyperthermia in the Post-Genomics era: new perspectives on an old concept. Anesthesiology. 2018;128:168\u201380. https:\/\/doi.org\/10.1097\/ALN.0000000000001878.","journal-title":"Anesthesiology"},{"issue":"5","key":"3766_CR20","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/anae.15317","volume":"76","author":"PM Hopkins","year":"2021","unstructured":"Hopkins PM, Girard T, Dalay S, Jenkins B, Thacker A, Patteril M, McGrady E. Malignant hyperthermia 2020: guideline from the association of anaesthetists. Anaesthesia. 2021;76(5):655\u201364. https:\/\/doi.org\/10.1111\/anae.15317.","journal-title":"Anaesthesia"},{"key":"3766_CR21","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1136\/bmjgh-2015-000011","volume":"1","author":"JS Ng-Kamstra","year":"2016","unstructured":"Ng-Kamstra JS, Greenberg S, Abdlaullah F, Amado V, Anderson GA, Cossa M, et al. Global surgery 2030: a roadmap for high income country actors. BMJ Glob Health. 2016;1:e11. https:\/\/doi.org\/10.1136\/bmjgh-2015-000011.","journal-title":"BMJ Glob Health"},{"issue":"3","key":"3766_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cge.14475","volume":"105","author":"Z Cong","year":"2024","unstructured":"Cong Z, Wan T, Wang J, Feng L, Cao C, Li Z, et al. Epidemiological and clinical features of malignant hyperthermia: A scoping review. Clin Genet. 2024;105(3):233\u201342. https:\/\/doi.org\/10.1111\/cge.14475.","journal-title":"Clin Genet"},{"key":"3766_CR23","doi-asserted-by":"publisher","unstructured":"Chang L, Motley R, Daly CL, Diggle CP, Hopkins PM, Shaw MA. An association between OXPHOS-related gene expression and malignant hyperthermia susceptibility in human skeletal muscle biopsies. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25063489","DOI":"10.3390\/ijms25063489"},{"key":"3766_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13395-020-00243-4","volume":"10","author":"TA Lawal","year":"2020","unstructured":"Lawal TA, Todd JJ, Witherspoon JW, Bonnemann CG, Dowling JJ, Hamilton SL, et al. Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature. Skelet Muscle. 2020;10:32. https:\/\/doi.org\/10.1186\/s13395-020-00243-4.","journal-title":"Skelet Muscle"},{"key":"3766_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.bja.2024.06.048","volume":"133","author":"TT Joseph","year":"2024","unstructured":"Joseph TT, Bu W, Haji-Ghassemi O, Chen YS, Woll K, Allen PD, et al. Propofol binds and inhibits skeletal muscle Ryanodine receptor 1. Br J Anaesth. 2024;133:1093\u2013100. https:\/\/doi.org\/10.1016\/j.bja.2024.06.048.","journal-title":"Br J Anaesth"},{"key":"3766_CR26","doi-asserted-by":"publisher","unstructured":"Tsuboi Y, Oyama K, Kobirumaki-Shimozawa F, Murayama T, Kurebayashi N, Tachibana T, et al. Mice with R2509C-RYR1 mutation exhibit dysfunctional Ca2\u2009+\u2009dynamics in primary skeletal myocytes. J Gen Physiol. 2022;154. https:\/\/doi.org\/10.1085\/jgp.202213136.","DOI":"10.1085\/jgp.202213136"},{"key":"3766_CR27","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.2147\/JMDH.S387208","volume":"15","author":"L Tan","year":"2022","unstructured":"Tan L, Teng Y, Yu H, Liu C, Xiao K, Yin J, et al. Clinical features of suspected malignant hyperthermia in China from 2015 to 2020: A retrospective study from China malignant hyperthermia emergency assistance group. J Multidiscip Healthc. 2022;15:3005\u201313. https:\/\/doi.org\/10.2147\/JMDH.S387208.","journal-title":"J Multidiscip Healthc"},{"key":"3766_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/ALN.0000000000003998","volume":"3","author":"Z Li","year":"2022","unstructured":"Li Z, Liu K. Dantrolene available in China for malignant hyperthermia treatment. Anesthesiology. 2022;3:515\u20136. https:\/\/doi.org\/10.1097\/ALN.0000000000003998.","journal-title":"Anesthesiology"},{"key":"3766_CR29","doi-asserted-by":"publisher","first-page":"844482","DOI":"10.1016\/j.bjane.2024.844482","volume":"74","author":"C Souza","year":"2024","unstructured":"Souza C, Almeida CS, Andrade PV, Santos JM, Amaral J, Silva H. Retrospective analysis of 20 years of activity of the Brazilian malignant hyperthermia hotline service. Braz J Anesthesiol. 2024;74:844482. https:\/\/doi.org\/10.1016\/j.bjane.2024.844482.","journal-title":"Braz J Anesthesiol"},{"key":"3766_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/bja\/aeq243","volume":"105","author":"KP Glahn","year":"2010","unstructured":"Glahn KP, Ellis FR, Halsall PJ, Muller CR, Snoeck MM, Urwyler A, et al. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European malignant hyperthermia group. Br J Anaesth. 2010;105:417\u201320. https:\/\/doi.org\/10.1093\/bja\/aeq243.","journal-title":"Br J Anaesth"},{"issue":"1","key":"3766_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bja.2024.09.022","volume":"134","author":"K Glahn","year":"2025","unstructured":"Glahn K, Girard T, Hellblom A, Hopkins PM, Johannsen S, Ruffert H, et al. Recognition and management of a malignant hyperthermia crisis: updated 2024 guideline from the European malignant hyperthermia group. Br J Anaesth. 2025;134(1):221\u20133. https:\/\/doi.org\/10.1016\/j.bja.2024.09.022.","journal-title":"Br J Anaesth"},{"key":"3766_CR32","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2147\/RMHP.S454895","volume":"17","author":"J Wang","year":"2024","unstructured":"Wang J, Yu Y, Gao Y, Wan T, Cong Z, Li Z, et al. The anesthesiologists\u2019 perception of malignant hyperthermia and availability of Dantrolene in China: A Cross-Sectional survey. Risk Manag Healthc Policy. 2024;17:763\u201373. https:\/\/doi.org\/10.2147\/RMHP.S454895.","journal-title":"Risk Manag Healthc Policy"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03766-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:05:03Z","timestamp":1751367903000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03766-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03766-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}